February 2020
Jernigan DB, CDC COVID-19 Response Team. Update: Public Health Response to the Coronavirus Disease 2019 Outbreak — United States, February 24, 2020 MMWR. 2020;69(8);216–9.
This report summarizes the aggressive measures that CDC, state and local health departments, multiple other federal agencies, and other partners are implementing to slow and try to contain transmission of COVID-19 in the United States…- Dawood FS, Chung JR, Kim SS, Zimmerman RK, Nowalk MP, Jackson ML, et al. Interim Estimates of 2019–20 Seasonal Influenza Vaccine Effectiveness — United States, February 2020 MMWR. 2020;69(7);177–182.
Vaccination remains the best way to protect against influenza and its potentially serious complications… - Patel A, Jernigan DB, 2019-nCoV CDC Response Team. Initial Public Health Response and Interim Clinical Guidance for the 2019 Novel Coronavirus Outbreak — United States, December 31, 2019–February 4, 2020 MMWR. 2020;69(5)140-6.
As more is learned about this novel virus and this outbreak, CDC will rapidly incorporate new knowledge into guidance for action by CDC and state and local health departments… - Oliver SE, Moore KL. Licensure of a Diphtheria and Tetanus Toxoids and Acellular Pertussis, Inactivated Poliovirus, Haemophilus influenzae Type b Conjugate, and Hepatitis B Vaccine, and Guidance for Use in Infants MMWR. 2020;69(5);136-9.
This report summarizes the indications for DTaP-IPV-Hib-HepB and provides guidance for its use… - Freedman MS, Hunter P, Ault K, Kroger A. Advisory Committee on Immunization Practices Recommended Immunization Schedule for Adults Aged 19 Years or Older — United States, 2020 MMWR. 2020;69(5);133-5.
Changes in the 2020 adult immunization schedule for persons aged ≥19 years include new or revised recommendations for hepatitis A vaccine (HepA); human papillomavirus vaccine (HPV); influenza vaccine; serogroup B meningococcal vaccine (MenB); pneumococcal vaccine; and tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine (Tdap)… - Robinson CL, Bernstein H, Poehling K, Romero JR, Szilagyi P. Advisory Committee on Immunization Practices Recommended Immunization Schedule for Children and Adolescents Aged 18 Years or Younger — United States, 2020 MMWR. 2020;69(5);130–2.
Changes in the 2020 child and adolescent immunization schedule for persons aged 18 years or younger include new or updated ACIP recommendations for hepatitis A vaccine (HepA); influenza vaccine; meningococcal B vaccine (MenB); and tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine (Tdap)…
January 2020
- Havers FP, Moro PL, Hunter P, Hariri S, Bernstein H. Use of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccines: Updated Recommendations of the Advisory Committee on Immunization Practices — United States, 2019 MMWR. 2020;69(3):77–83.
This report provides recommendations for the use of Td or Tdap for the decennial Td booster, tetanus prophylaxis when indicated for wound management, and catch-up immunization schedule for persons aged ≥7 years with incomplete or unknown vaccination history… - Merritt TA, Rasmussen SA, Bright MA, Roussos-Ross D, Sims SM, Gurka MJ, et al. Variation in Tdap and Influenza Vaccination Coverage Among Pregnant Women by Insurance Type — Florida, 2016–2018 MMWR. 2020;69(3);72–76.
Medicaid benefits for Tdap and influenza vaccination during pregnancy might increase vaccination coverage… - Owusu D, Hand J, Tenforde MW, Feldstein LR, DaSilva J, Barnes J, et al. Early Season Pediatric Influenza B/Victoria Virus Infections Associated with a Recently Emerged Virus Subclade — Louisiana, 2019 MMWR. 2020;69(2);40-43.
Early influenza B/Victoria virus activity in Louisiana resulted in illnesses in children that were similar to typical seasonal influenza; however, some illnesses were severe, and one death was reported…
No comments:
Post a Comment